Apax Weighs Sale of $1 Billion Device Maker Candela

Apax Partners is weighing a sale of Candela Medical in a deal that could value the aesthetic device maker at more than $1 billion, people with knowledge of the matter said.

The private equity firm is sounding out potential suitors, including other buyout firms, the people said, asking not to be identified discussing confidential information. Candela filed for a Nasdaq listing in October that was later postponed.